← Back to Search

ViOptix T.Ox for Skin Flap Necrosis

N/A

Waitlist Available

Led By Ramon Llull, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up hour 0.5

Awards & highlights

Study Summary

This trial studies the effects of blood pressure cuff on tissue oxygenation in the arm & hand. A cuff is inflated, monitored every 2 min, then deflated.

Eligible Conditions

Skin Flap Necrosis
Postoperative Complications

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ hour 0.5

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~hour 0.5

This trial's timeline: 3 weeks for screening, Varies for treatment, and hour 0.5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Transcutaneous Oximetry (StO2) of Vascular Occlusion Test at 0.5 Hours

Trial Design

1Treatment groups

Experimental Treatment

Group I: ViOptix T.OxExperimental Treatment1 Intervention

ViOptix T.Ox machine is used to measure the oxygenation of composite tissue.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ViOptix

2022

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,240 Previous Clinical Trials

1,004,169 Total Patients Enrolled

Ramon Llull, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Tissue Oximetry Clinical Trial Eligibility Overview. Trial Name: NCT05592145 — N/A

Skin Flap Necrosis Research Study Groups: ViOptix T.Ox

Skin Flap Necrosis Clinical Trial 2023: Tissue Oximetry Highlights & Side Effects. Trial Name: NCT05592145 — N/A

Tissue Oximetry 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592145 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial allow for minors to participate?

"The age range for participants in this trial is 18-65. For those below the legal age of consent, there are 19 studies available and 177 for older individuals that exceed the accepted upper limit."

Answered by AI

Do I meet the qualifications to join this experiment?

"This clinical investigation seeks 32 individuals with dermal afflictions aged between 18 and 65. To be eligible, potential participants must meet the requirements of age (18 - 65)."

Answered by AI

Does this research have any current openings?

"Per the records on clinicaltrials.gov, this experimental study is currently seeking out participants. The trial was first made available to the public on November 10th 2022 and has since been updated as recently as 28th of that same month."

Answered by AI

What is the population size of individuals involved in this medical experiment?

"Affirmative. Clinicaltrials.gov confirms that, since being posted on November 10th 2022 and updated on the 28th of the same month, this trial is actively seeking participants to enrol. 32 patients are required from one medical centre for this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quantifying the Venous Congestion Curve of a Tissue Oximetry Device

2022. "Quantifying the Venous Congestion Curve of a Tissue Oximetry Device". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05592145.